Want to see AU:ALC full AI Analyst Report?
ALC Stock Chart & Stats
AU$0.09
>-AU$0.01(-3.37%)
At close: 4:00 PM EDT
AU$0.09
>-AU$0.01(-3.37%)
Day’s Range― - ―
52-Week RangeAU$0.08 - AU$0.15
Previous CloseN/A
Volume2.06M
Average Volume (3M)796.98K
Market Cap
AU$118.23M
Enterprise ValueAU$127.81
Total Cash (Recent Filing)AU$14.20M
Total Debt (Recent Filing)AU$1.32M
Price to Earnings (P/E)30.3
Beta0.97
Next Earnings
Sep 02, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding1,343,558,700
10 Day Avg. Volume536,053
30 Day Avg. Volume796,979
Financial Highlights & Ratios
PEG Ratio-0.70
Price to Book (P/B)1.57
Price to Sales (P/S)3.38
P/FCF Ratio24.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.14Price Target Upside58.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)<0.01
Revenue Forecast (FY)AU$53.97M
Bulls Say, Bears Say
Bulls Say
Recurring Revenue ModelAlcidion’s core business is recurring software licences, subscriptions and support plus implementation services. That mix creates predictable renewal cash flows, opportunities to upsell modules and long contract durations that smooth revenues and support durable customer relationships over years.
Strong Revenue Growth & High Gross MarginSustained double-digit revenue growth combined with an exceptionally high gross margin reflects scalable software economics: incremental sales carry low incremental cost. Over the medium term this supports operating leverage if fixed costs are controlled and drives durable cash generation as deployments expand.
Very Low Leverage And Strong Free Cash Flow ImprovementExtremely low leverage minimizes solvency risk and preserves capacity to invest or pursue M&A. The dramatic FCF improvement and near parity of FCF to net income signal stronger cash conversion, enabling reinvestment in product, customer success and international expansion without heavy external financing.
Bears Say
Negative EBIT / Weak Operating ProfitabilityA negative EBIT margin indicates core operations still struggle to cover operating costs despite healthy gross margins. This structural operating shortfall suggests the company must improve cost structure, scale professional services or pricing to sustainably convert revenue into operating profits.
Low Return On EquityA low ROE implies limited profitability on shareholder capital and may reflect underutilised assets or thin margins. Persistently low ROE reduces long-term returns for investors and constrains the ability to fund growth internally without either materially improving margins or increasing capital efficiency.
Modest Operating Scale (small Headcount)A relatively small workforce can limit the company’s capacity to scale large, complex hospital implementations and global expansion. Professional services heavy deployments require regional teams; constrained headcount may slow rollout, increase reliance on partners, and pressure margins as growth accelerates.
Alcidion Group Limited News
ALC FAQ
What was Alcidion Group Limited’s price range in the past 12 months?
Alcidion Group Limited lowest share price was AU$0.08 and its highest was AU$0.14 in the past 12 months.
What is Alcidion Group Limited’s market cap?
Alcidion Group Limited’s market cap is AU$118.23M.
When is Alcidion Group Limited’s upcoming earnings report date?
Alcidion Group Limited’s upcoming earnings report date is Sep 02, 2026 which is in 31 days.
How were Alcidion Group Limited’s earnings last quarter?
Alcidion Group Limited released its earnings results on Feb 25, 2026. The company reported AU$0.001 earnings per share for the quarter, beating the consensus estimate of AU$0 by AU$0.001.
Is Alcidion Group Limited overvalued?
According to Wall Street analysts Alcidion Group Limited’s price is currently Undervalued.
Does Alcidion Group Limited pay dividends?
Alcidion Group Limited does not currently pay dividends.
What is Alcidion Group Limited’s EPS estimate?
Alcidion Group Limited’s EPS estimate is 0.
How many shares outstanding does Alcidion Group Limited have?
Alcidion Group Limited has 1,343,558,700 shares outstanding.
What happened to Alcidion Group Limited’s price movement after its last earnings report?
Alcidion Group Limited reported an EPS of AU$0.001 in its last earnings report, beating expectations of AU$0. Following the earnings report the stock price went down -4.545%.
Which hedge fund is a major shareholder of Alcidion Group Limited?
Currently, no hedge funds are holding shares in AU:ALC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Alcidion Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$0.14 (58.33% Upside)
AU$0.14 (58.33% Upside)
Blogger Sentiment
Bullish
AU:ALC Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.66%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.82%
Trailing 12-Months
Company Description
Alcidion Group Limited
Alcidion Group Limited operates as a healthcare technology firm, specializing in the creation and licensing of software products across Australia, New Zealand, and the United Kingdom. Its flagship product, Miya Precision, is a consolidated platform built on the Fast Healthcare Interoperability Resources (FHIR) standard, aimed at enabling intelligent healthcare delivery. The company also supplies Smartpage, a mobile and web-based system designed to streamline hospital communications and task management for clinical and administrative personnel. Additional solutions include Patientrack, a tool for real-time patient monitoring and risk screening; Silverlink, which handles patient administration; and ExtraMed, software dedicated to optimizing clinical and patient flow. Furthermore, Alcidion provides a range of services encompassing product deployment, support and maintenance, systems integration, and data analysis. Founded in 2000 and headquartered in South Yarra, Australia, the company was formerly known as Alcidion Corporation Pty Ltd until its rebranding as Alcidion Group Limited in December 2015.
ALC Stock 12 Month Forecast
Average Price Target
AU$0.14
▲(58.33% Upside)
Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1
―
Pro Medicus Limited
―
Mach7 Technologies
―
Beamtree Holdings Ltd
―
Artrya Limited
―








